JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JVI Accepts, published online ahead of print on 26 December 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.02474-07v1
82/6/3154    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kasprowicz, V.
Right arrow Articles by Lauer, G. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kasprowicz, V.
Right arrow Articles by Lauer, G. M.

 Previous Article

J. Virol. doi:10.1128/JVI.02474-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

High PD-1 expression on HCV-specific CD8+ and CD4+ T cells during acute Hepatitis C irrespective of clinical outcome

Victoria Kasprowicz, Julian Schulze zur Wiesch, Thomas Kuntzen, Brian E. Nolan, Steven Longworth, Andrew Berical, Jenna Blum, Cory McMahon, Laura L. Reyor, Nahel Elias, William W. Kwok, Barbara G. McGovern, Gordon Freeman, Raymond T. Chung, Paul Klenerman, Lia Lewis-Ximenez, Bruce D. Walker, Todd M. Allen, Arthur Y. Kim, and Georg M. Lauer*

Partners AIDS Research Center, Massachusetts General Hospital, Harvard Medical School, 149 13th Street 6th Floor Room 6001, Charlestown, MA 02129-2000 USA, Med. Klinik I, Universität Hamburg, Germany, Transplantation Unit, Department of Surgery, Massachusetts General Hosptital, Boston, MA 02114, USA, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA, Lemuel Shattuck Hospital, Boston, MA Tufts University School of Medicine, Boston, MA, USA, Department of Medical Oncology, Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA, Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA, Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, South Parks Road, Oxford OX1 3SY, UK, Departmento de Virologia, Instituto Oswaldo Cruz/Fiocruz, Rio de Janeiro, RJ, Brazil

* To whom correspondence should be addressed. Email: glauer{at}partners.org.


   Abstract

We monitored expression of PD-1 (a mediator of T cell exhaustion and viral persistence) on HCV-specific CD8+ and CD4+ T cells from blood and liver during acute, chronic and resolved infection. PD-1 expression on HCV-specific T cells was high early in acute infection irrespective of clinical outcome, and most cells continued to express PD-1 in resolved and chronic stages of infection; intrahepatic expression levels were especially high. Our results suggest that analysis of PD-1 expression alone is not sufficient to predict infection outcome or determine T cell functionality in HCV infection.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.